tiprankstipranks
Trending News
More News >
Nuvalent (NUVL)
NASDAQ:NUVL
US Market
Advertisement

Nuvalent (NUVL) Similar Stocks

Compare
122 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Nuvalent
$80.89
$5.83B
-4.79%
12 Buy
0 Hold
0 Sell
Strong Buy
Cytokinetics
$53.01
$6.34B
-5.05%
14 Buy
3 Hold
0 Sell
Strong Buy
TG Therapeutics
$32.21
$5.11B
86.08
35.62%
1 Buy
1 Hold
1 Sell
Hold
Axsome Therapeutics
$125.17
$6.25B
34.33%
16 Buy
0 Hold
0 Sell
Strong Buy
Merus
$67.47
$5.10B
33.95%
11 Buy
0 Hold
0 Sell
Strong Buy
Avidity Biosciences
$50.36
$6.24B
24.47%
18 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
NUVL
Nuvalent
80.89
-8.35
-9.36%
CYTK
Cytokinetics
53.01
-2.82
-5.05%
TGTX
TG Therapeutics
32.21
8.46
35.62%
AXSM
Axsome Therapeutics
125.17
31.08
33.03%
MRUS
Merus
67.47
17.33
34.56%
RNA
Avidity Biosciences
50.36
9.60
23.55%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis